NEI Research News

A College of Veterinary Medicine & Biomedical Sciences and College of Pharmacy team believes the medication may also translate to the treatment of cataracts and uveitis in humans.

The Kantorow Laboratory and research program have been continually funded by the NIH’s National Eye Institute for almost two decades.

U. Delaware's Salil Lachke identifies new mechanism essential for eye lens development.

Research funded by the National Eye Institute aims to reverse progression of cataracts—the most common cause of blindness worldwide—or to prevent them from forming altogether.

Four to 12 percent of people undergoing cataract surgery to replace a cloudy lens with a clear artificial one develop posterior capsule opacification (PCO).

As we age, proteins in the lenses of our eyes start misbehaving: They unfold and congregate in clusters that block, scatter and distort light as it passes through the lens.

Researchers at Florida Atlantic University are the first to show that cells in close proximity to each other can sense when a cell is dying due to environmental stressors like UV light and smoke, and eat the cell before it becomes toxic.

A chemical that could potentially be used in eye drops to reverse cataracts, the leading cause of blindness, has been identified by a team of scientists.

Loss or defects of a protein previously shown to play a key a role in cataract, the clouding of the lens that commonly strikes people in their seventies, has now been shown to contribute to presbyopia.

A team of scientists has established that a breakdown in communication between two biochemical pathways in the eye is involved in causing cataracts.